Published in Circulation on August 18, 2003
Non-invasive imaging in the diagnosis of acute viral myocarditis. Clin Res Cardiol (2009) 1.66
Coronary microvascular dysfunction: an update. Eur Heart J (2013) 1.28
Preamplification techniques for real-time RT-PCR analyses of endomyocardial biopsies. BMC Mol Biol (2008) 1.00
Autoimmunological features in inflammatory cardiomyopathy. Clin Res Cardiol (2007) 0.99
Human parvovirus PARV4 DNA in tissues from adult individuals: a comparison with human parvovirus B19 (B19V). Virol J (2010) 0.95
Parvovirus B19 genome in endomyocardial biopsy specimen. Circulation (2004) 0.93
Viral myocarditis: from experimental models to molecular diagnosis in patients. Heart Fail Rev (2013) 0.91
Phospholipase A2 activity-dependent stimulation of Ca2+ entry by human parvovirus B19 capsid protein VP1. J Virol (2006) 0.91
NS1 specific CD8+ T-cells with effector function and TRBV11 dominance in a patient with parvovirus B19 associated inflammatory cardiomyopathy. PLoS One (2008) 0.86
Inflammation, ECG changes and pericardial effusion: whom to biopsy in suspected myocarditis? Clin Res Cardiol (2006) 0.85
Viral heart disease: molecular diagnosis, clinical prognosis, and treatment strategies. Med Microbiol Immunol (2004) 0.85
Human Parvoviruses. Clin Microbiol Rev (2017) 0.84
Myocardial parvovirus B19 persistence: lack of association with clinicopathologic phenotype in adults with heart failure. Circ Heart Fail (2010) 0.83
Parvovirus B19 myocarditis causes significant morbidity and mortality in children. Pediatr Cardiol (2012) 0.82
Betaferon in chronic viral cardiomyopathy (BICC) trial: Effects of interferon-β treatment in patients with chronic viral cardiomyopathy. Clin Res Cardiol (2016) 0.82
Acute myocarditis mimicking ST-elevation myocardial infarction: A case report and review of the literature. Exp Ther Med (2015) 0.80
Immune-mediated and autoimmune myocarditis: clinical presentation, diagnosis and management. Heart Fail Rev (2013) 0.80
Immunomodulatory effects of mesenchymal stromal cells revisited in the context of inflammatory cardiomyopathy. Stem Cells Int (2013) 0.80
Selective regulation of cardiac organic cation transporter novel type 2 (OCTN2) in dilated cardiomyopathy. Am J Pathol (2011) 0.80
Myocarditis mimicking acute myocardial infarction. Neth Heart J (2015) 0.79
Human parvovirus B19: a mechanistic overview of infection and DNA replication. Future Virol (2015) 0.78
The Impact of Specific Viruses on Clinical Outcome in Children Presenting with Acute Heart Failure. Int J Mol Sci (2016) 0.77
[Molecular mechanisms and consequences of cardiac viral infections]. Pathologe (2008) 0.77
Green fluorescent protein (GFP) color reporter gene visualizes parvovirus B19 non-structural segment 1 (NS1) transfected endothelial modification. PLoS One (2012) 0.75
Infant acute myocarditis mimicking acute myocardial infarction. Autops Case Rep (2016) 0.75
Pathophysiological mechanisms of parvovirus B19 infection. J Clin Microbiol (2009) 0.75
Risk Factors for Cardiac Arrest or Mechanical Circulatory Support in Children with Fulminant Myocarditis. Pediatr Cardiol (2016) 0.75
Cardiovascular magnetic resonance in myocarditis: A JACC White Paper. J Am Coll Cardiol (2009) 6.41
Clinical Features and Outcomes of Takotsubo (Stress) Cardiomyopathy. N Engl J Med (2015) 6.00
Angiotensin-(1-7) is an endogenous ligand for the G protein-coupled receptor Mas. Proc Natl Acad Sci U S A (2003) 5.08
The cardiac mechanical stretch sensor machinery involves a Z disc complex that is defective in a subset of human dilated cardiomyopathy. Cell (2002) 4.72
Simultaneous PET-MRI: a new approach for functional and morphological imaging. Nat Med (2008) 4.54
Detection of viruses in myocardial tissues by polymerase chain reaction. evidence of adenovirus as a common cause of myocarditis in children and adults. J Am Coll Cardiol (2003) 4.51
Cardiovascular magnetic resonance assessment of human myocarditis: a comparison to histology and molecular pathology. Circulation (2004) 4.23
Hypomagnesemia with secondary hypocalcemia is caused by mutations in TRPM6, a new member of the TRPM gene family. Nat Genet (2002) 3.90
Utility of Doppler echocardiography and tissue Doppler imaging in the estimation of diastolic function in heart failure with normal ejection fraction: a comparative Doppler-conductance catheterization study. Circulation (2007) 3.76
Role of left ventricular stiffness in heart failure with normal ejection fraction. Circulation (2008) 3.56
Current state of knowledge on aetiology, diagnosis, management, and therapy of myocarditis: a position statement of the European Society of Cardiology Working Group on Myocardial and Pericardial Diseases. Eur Heart J (2013) 3.50
Presentation, patterns of myocardial damage, and clinical course of viral myocarditis. Circulation (2006) 3.20
Update on myocarditis. J Am Coll Cardiol (2012) 3.12
High prevalence of viral genomes and multiple viral infections in the myocardium of adults with "idiopathic" left ventricular dysfunction. Circulation (2005) 3.06
Intracoronary compared with intravenous bolus abciximab application during primary percutaneous coronary intervention in ST-segment elevation myocardial infarction: cardiac magnetic resonance substudy of the AIDA STEMI trial. J Am Coll Cardiol (2013) 2.91
Cardiovascular magnetic resonance in clinically suspected cardiac amyloidosis: noninvasive imaging compared to endomyocardial biopsy. J Am Coll Cardiol (2008) 2.82
Peginterferon plus adefovir versus either drug alone for hepatitis delta. N Engl J Med (2011) 2.72
Protective role of angiopoietin-1 in endotoxic shock. Circulation (2004) 2.53
Enforced viral replication activates adaptive immunity and is essential for the control of a cytopathic virus. Nat Immunol (2011) 2.51
Impaired renal Na(+) retention in the sgk1-knockout mouse. J Clin Invest (2002) 2.47
The reno-vascular A2B adenosine receptor protects the kidney from ischemia. PLoS Med (2008) 2.43
Interferon-beta treatment eliminates cardiotropic viruses and improves left ventricular function in patients with myocardial persistence of viral genomes and left ventricular dysfunction. Circulation (2003) 2.33
Cardiac inflammation contributes to changes in the extracellular matrix in patients with heart failure and normal ejection fraction. Circ Heart Fail (2010) 2.30
Integrated structural analysis of the human nuclear pore complex scaffold. Cell (2013) 2.25
Viral persistence in the myocardium is associated with progressive cardiac dysfunction. Circulation (2005) 2.15
Procoagulant soluble tissue factor is released from endothelial cells in response to inflammatory cytokines. Circ Res (2005) 2.09
Phenotypic characterization of infiltrates in dilated cardiomyopathy - diagnostic significance of T-lymphocytes and macrophages in inflammatory cardiomyopathy. Med Sci Monit (2002) 2.08
Predictors of outcome in patients with suspected myocarditis. Circulation (2008) 2.03
Diagnostic synergy of non-invasive cardiovascular magnetic resonance and invasive endomyocardial biopsy in troponin-positive patients without coronary artery disease. Eur Heart J (2009) 1.98
Myocarditis: early biopsy allows for tailored regenerative treatment. Dtsch Arztebl Int (2012) 1.88
Suspected chronic myocarditis at cardiac MR: diagnostic accuracy and association with immunohistologically detected inflammation and viral persistence. Radiology (2008) 1.87
Contribution of E-NTPDase1 (CD39) to renal protection from ischemia-reperfusion injury. FASEB J (2007) 1.84
Connective tissue growth factor: a crucial cytokine-mediating cardiac fibrosis in ongoing enterovirus myocarditis. J Mol Med (Berl) (2007) 1.83
Impact of the hepatitis B virus genotype and genotype mixtures on the course of liver disease in Vietnam. Hepatology (2006) 1.82
Cardiac deletion of the Coxsackievirus-adenovirus receptor abolishes Coxsackievirus B3 infection and prevents myocarditis in vivo. J Am Coll Cardiol (2009) 1.81
Renin inhibition improves cardiac function and remodeling after myocardial infarction independent of blood pressure. Hypertension (2008) 1.78
Diagnostic performance of CMR imaging compared with EMB in patients with suspected myocarditis. JACC Cardiovasc Imaging (2012) 1.77
High prevalence of viral genomes and inflammation in peripartum cardiomyopathy. Am J Obstet Gynecol (2005) 1.73
Long-term cardiac-targeted RNA interference for the treatment of heart failure restores cardiac function and reduces pathological hypertrophy. Circulation (2009) 1.71
Achievement of guideline-defined treatment goals in primary care: the German Coronary Risk Management (CoRiMa) study. Eur Heart J (2007) 1.69
Differential use of importin-α isoforms governs cell tropism and host adaptation of influenza virus. Nat Commun (2011) 1.65
Enhancement of the endothelial NO synthase attenuates experimental diastolic heart failure. Basic Res Cardiol (2009) 1.62
Inflammation as a therapeutic target in heart failure? A scientific statement from the Translational Research Committee of the Heart Failure Association of the European Society of Cardiology. Eur J Heart Fail (2009) 1.61
Left ventricular dysfunction induced by nonsevere idiopathic pulmonary arterial hypertension: a pressure-volume relationship study. Am J Respir Crit Care Med (2012) 1.59
Development of diastolic heart failure in a 6-year follow-up study in patients after acute myocarditis. Heart (2010) 1.57
Laminin-alpha4 and integrin-linked kinase mutations cause human cardiomyopathy via simultaneous defects in cardiomyocytes and endothelial cells. Circulation (2007) 1.57
G-protein-coupled receptor Mas is a physiological antagonist of the angiotensin II type 1 receptor. Circulation (2005) 1.57
Annual distribution of ventricular tachycardias and ventricular fibrillation. Am Heart J (2003) 1.56
Vascular-protective effects of high-density lipoprotein include the downregulation of the angiotensin II type 1 receptor. Hypertension (2009) 1.54
Long-term follow-up of biopsy-proven viral myocarditis: predictors of mortality and incomplete recovery. J Am Coll Cardiol (2012) 1.53
3 Tesla MRI-detected brain lesions after pulmonary vein isolation for atrial fibrillation: results of the MACPAF study. J Cardiovasc Electrophysiol (2012) 1.52
Highly pathogenic influenza virus infection of the thymus interferes with T lymphocyte development. J Immunol (2010) 1.51
Detection of high-risk human papillomavirus E6 and E7 oncogene transcripts in cervical scrapes by nested RT-polymerase chain reaction. J Med Virol (2004) 1.50
Protease-activated receptor-2 regulates the innate immune response to viral infection in a coxsackievirus B3-induced myocarditis. J Am Coll Cardiol (2013) 1.50
Myeloperoxidase acts as a profibrotic mediator of atrial fibrillation. Nat Med (2010) 1.49
Angiotensin II type 1 receptor agonistic antibodies reflect fundamental alterations in the uteroplacental vasculature. Hypertension (2005) 1.48
Humoral anti-proteasomal autoimmunity in dilated cardiomyopathy. Basic Res Cardiol (2010) 1.47
Images in cardiovascular medicine. Cardiomyopathy in a Duchenne muscular dystrophy carrier and her diseased son: similar pattern revealed by cardiovascular MRI. Circulation (2010) 1.47
Giant cell myocarditis mimicking idiopathic fascicular ventricular tachycardia. J Heart Lung Transplant (2008) 1.46
Fatal parvovirus B19 myocarditis in an 8-year-old boy. J Forensic Sci (2003) 1.45
The role of NT-proBNP in the diagnostics of isolated diastolic dysfunction: correlation with echocardiographic and invasive measurements. Eur Heart J (2005) 1.44
Myocardial gene expression profiles and cardiodepressant autoantibodies predict response of patients with dilated cardiomyopathy to immunoadsorption therapy. Eur Heart J (2012) 1.44
Human parvovirus B19-associated myocarditis. N Engl J Med (2010) 1.43